Biocon signs MOU with Deakin University, Australia

Biocon Ltd on June 07, 2007 has announced that it is entering into a Memorandum of Understanding with Deakin University, Victoria, Australia's fastest growing University in multi disciplinary research with greater focus in biotechnology and biosciences research.

The territories covered in the Memorandum of Understanding include:

- The establishment of the Deakin Research Institute in Bangalore.

- Joint development of a mammalian cell bio-processing facility at Geelong, Victoria, Australia.

- Deakin through its Metabolic Research Unit will undertake research in the areas of metabolic diseases on behalf of the Company.

Given the industry's need for high levels of innovation and increased productivity, the Company frequently supplements its R&D efforts by working with academic institutions and biotechnology companies across the world. The Company's R&D strategy encourages a symbiotic environment that draws on collective resources and knowledge. With Deakin's proven capability to research in multi- disciplinary environment the tie-up will attempt to harness this expertise in providing solutions in the area of mammalian cell bio-processing and metabolic diseases.

"The signing of this MOU will formally initiate collaboration in research and education between Biocon and Deakin University, Australia. This partnership will provide valuable access to a world of medical knowledge and scientific training, together with opportunities for exchange of scientists to facilitate projects in areas of mutual interest" said Ms. Kiran Mazumdar-Shaw, CMD, of the Company.

Source : Equity Bulls

Keywords